BioXyTran
is a developer of anti-necrosis drugs to prevent catastrophic brain damages... Read moreBioXyTran
is a developer of anti-necrosis drugs to prevent catastrophic brain damages... Read more
News
Conference Presentation
Feb 04, 2026
Yahoo
Bioxytran CEO David Platt, Ph.D. to Present at Noble Capital Markets' Emerging Growth Virtual Equity Conference
Partnership
Feb 02, 2026
Marketscreener
Bioxytran, Inc. and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
BioXyTran Competitors
1
2
3
4
5
6
7
8
9
10